Location: Home > Pharma China Web Edition
  • search
  • go
  • Product/R&D News
  • 12/2/2020LG Chem and TransThera Announce FDA Clearance of IND for SSAO/VAP-1 I...
  • 12/1/2020LianBio Cleared for Phase 2a Trial of Anticancer Infigratinib in China
  • 11/30/2020Junshi Biosciences Announces NMPA Acceptance of Its IND for JS006
  • 11/25/2020Antengene Granted Chinese Approval for Phase I/II Trial of ATG-016 (El...
  • 11/25/2020Sinopharm Seeking Chinese Approval for COVID-19 Vaccine (Free)
  • 11/24/2020Basilea and Pfizer Files NDA for Antifungal Cresemba in China
  • 11/24/2020Ascentage Approved for Two PIb/II Trials of the Bcl-2 Inhibitor APG-2...
  • 11/23/2020Onconova Files IND for Multi-kinase CDK4/6 Inhibitor in the U.S.
  • 11/19/2020MSD Files NDA for Antiviral Prevymis (Letermovir) in China
  • 11/18/2020Experimental Medicine Research Institute established in Shanghai
  • 11/16/2020Tracon Pharma Files NDA for Anticancer Envafolimab in China
  • 11/12/2020Takeda, OrigiMed to Develop Genomic-based Clinical Treatment Platform
  • 11/12/2020Apollomics Granted IND Approval for APL-102 to Initiate a Phase 1 Stud...
  • 11/11/2020Nicox Begins 2nd P3 Trial of NCX 470 for Open-angle Glaucoma or Ocular...
  • 11/11/2020CStone Announces NMPA Acceptance of Its NDA for Sugemalimab in Firs...
  • 11/11/2020NMPA Accepts Fosun Pharma Clinical Trial Application Of mRNA Vaccine C...
  • 11/10/2020Innovent Reports on Phase 1a Results of CD47 mAb (Letaplimab) for Ad...
  • 11/9/2020EUSA Pharma and BeiGene Announce BLA Acceptance for QARZIBA in China
  • 11/9/2020Brazil Suspends and Then Resumes Trials of Sinovac COVID-19 Vaccine
  • 11/7/2020SK Biopharma Sees Promising Outlook of Its Epilepsy Drug XCOPRI in Asi...
  • 11/7/2020AstraZeneca To Start Covid Vaccine Trials In China (Free)
  • 11/5/2020Asieris Approved of P3 Trial of Its Novel Single Oral Agent as First-l... (Free)
  • 11/2/2020One More Chinese COVID-19 Vaccine Ready for Phase-3 Clinical Trials
  • 10/29/2020Asieris Approved for Ph 1 Trial of Bladder Cancer Drug in Australia
  • 10/28/2020Aprinoia Announces NMPA Approval to Initiate Phase 3 Trial for 18F-A...
  • 10/27/2020EdiGene Files IND for Its CRISPR/Cas 9 Gene-editing Hematopoietic Stem...
  • 10/22/2020Priority Review Granted to Ascentage Pharma's NDA for Olverembatinib (... (Free)
  • 10/16/2020Daiichi Sankyo Submits IND Application for ADC Medicine Enhertu (DS-82...
  • 10/15/2020Eisai's sNDAs for Anti-Epileptic Drug Fycompa Accepted in China
  • 10/12/2020Antengene Establishes New Drug Discovery Center in Shanghai (Free)
  • Page:1/7 Total number of articles:206: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group